DM Clinical Research Forms Inaugural Advisory Board to Accelerate Growth and Innovation

HOUSTON, Oct. 8, 2025 /PRNewswire/ — DM Clinical Research, a leading multi-therapeutic site network, today announced the formation of its inaugural Advisory Board. Comprising respected leaders from clinical research and healthcare, the Board will provide strategic counsel to DM Clinical’s Executive Leadership Team on growth priorities, operational excellence, and emerging trends shaping the future of clinical trials.

“As we enter an exciting phase of growth, we are honored to partner with such distinguished leaders,” said Mohammad Millwala, CEO. “As a privately held, founder-led organization, our leadership team is accountable for executing a data-driven expansion plan. The Advisory Board’s expertise and networks will help us scale responsibly while advancing patient-centric research.”

The Advisory Board includes leaders such as Kushal Gohil, SVP, Global Project Leadership & Launch Excellence at Parexel. Gohil brings decades of leadership experience across the CRO sector, with a track record in large-scale organizational initiatives spanning operations, corporate strategy, corporate development, sales operations, brand management, market research, and account management. He holds an MBA from MIT Sloan, a Bachelor of Pharmacy from the University of Pune, and master’s degrees in Drug Development and Marketing from the University of Cincinnati.

“I’m honored to join DM Clinical Research’s inaugural Advisory Board,” said Gohil. “Patients and sites are at the heart of every clinical trial, and I’m excited to help advance DM Clinical’s mission to deliver innovative solutions that put patients first, empower sites, and drive meaningful progress in clinical research.”

About DM Clinical Research

DM Clinical Research is an integrated multi-therapeutic national network of clinical trial sites headquartered in Houston, Texas. Founded in 2006, the company includes over 35 research centers and physician practice embedded sites, servicing a range of therapeutic areas across the nation. DM Clinical Research received the 2024 Society for Clinical Research Sites Site Spark Award and the 2023 Best Clinical Trial Network Award by World Vaccine Congress. Through its partnerships with prominent global pharmaceutical sponsors, DM Clinical Research brings opportunities to the community to participate in cutting-edge research under the careful medical supervision of qualified physicians and professionals. For more information, please visit dmclinical.com or call (281) 517-0550.

View original content:https://www.prnewswire.com/news-releases/dm-clinical-research-forms-inaugural-advisory-board-to-accelerate-growth-and-innovation-302576284.html

SOURCE DM Clinical Research